Global bio-pharma clinical leaders to call for industry transformation at 21st Annual Partnerships in Clinical Trials

Clinical development, outsourcing and operations decision makers from the world’s top bio-pharmaceutical and medical device manufacturers and their clinical research partners will meet on March 4-7, 2012, at the 21st Annual Partnerships in Clinical Trials (PCT) conference in Orlando, Florida, USA, with a renewed mandate for change at a critical point in the industry’s history.

For 20 years, PCT has been committed to enabling clinical research sponsors and contract research organizations (CROs) optimize strategic partnerships, forge new relationships and find collaborative solutions to perennial challenges. But, according to the conference co-chairmen, next year’s program reflects a much more progressive agenda aimed at the productive disruption of conventional clinical research practices.